Specialty Chemicals company Tatva Chintan Pharma Chem announced Q1FY26 results Revenue from Operations: Rs 1,169 million compared to Rs 1,055 million during Q1FY25, change 11%. EBIDTA: Rs 173 million compared to Rs 126 million during Q1FY25, change 37%. EBIDTA Margin: 14.8% for Q1FY26. PAT: Rs 67 million compared to Rs 52 million during Q1FY25, change 28%. PAT Margin: 5.7% for Q1FY26. EPS: Rs 2.84 for Q1FY26. Result PDF